the aid library

LIST OPTIONS

Filter

4138

Health promotion for Latin Americans with intellectual disabilities

G.C Frey, and V. A Temple (2008) CC

salud pública de méxico / vol. 50, suplemento 2 de 2008, pp.167-177. In response to the emerging global concern regarding health and people with intellectual disabilities (ID), several developed countries have established national initiatives to address the unique health needs of this population ... more

Download (589)

View PDF (1074)

Uganda: Ebola Preparedness Emergency Plan of Action (EPoA) - DREF Operation n° MDRUG041

International Federation of Red Cross And Red Crescent Societies (2018) C1

Following the declaration of the 9th Ebola Disease Outbreak (EVD) on 8 May 2018 by the Democratic Republic of Congo (DRC) Ministry of Health, the WHO has raised the alert for neighbouring countries of the Democratic Republic of the Congo (DRC) which share extensive borders, hosting DRC refugees and ... more

Download (455)

View PDF (951)

‘ELIMU KWANZA!’ - A Brighter Future for the Children of DRC Safe Education for Internally Displaced Children in the Democratic Republic of Congo

War Child Holland War Child Holland (2014) C1

Prioritise education in conflict-affected areas: Across the world 28 million1 primary school-age children living in conflict-affected countries are out-of-school, and they form half of the world’s total out-of-school population. During conflict, infrastructure assets such as schools are damaged... more

Download (435)

View PDF (563)

Assist - The Alcohol, Smoking and Substance Involvement Screening Test (ASSIST)

R. Humeniuk, S. Henry-Edwards, R. Ali; et al. World Health Organization WHO (2010) C_WHO

Manual for use in primary care. There is substantial evidence for the benefits of screening and brief intervention in primary health care for alcohol problems. However, there is a need for screening and brief interventions with cross-cultural relevance for substances other than alcohol or tobacco,... more

Download (371)

View PDF (320)

Improving HIV outcomes: Framework and Toolkit for south-to-south technical assistance in the PEPFAR gender strategic areas

M. Gutmann; L. Messner, L. Crye USAID; PEPFAR; AIDS Free (Strenghtening High Impact Interventions for a AIDS-free Generation); JSI Research & Training Institute; et al. (2015) C2

Jury 2015

Download (414)

View PDF (419)

Tackling antimicrobial use and resistance in pig production: lessons learned in Denmark

Food and Agriculture Organization of the United Nations FAO (2019) C2

This publication describes an arduous campaign to tackle the use of antimicrobials - specifically antibiotics - in the Danish swine-producing sector thanks to the collaboration between the regulatory sector within the Ministry of Environment and Food, private veterinary practitioners and swine produ... more

Download (482)

View PDF (333)

Self-Reliance Index, Version 2.0: Indicators to measure progress towards self-reliance

Buscher D., Slaughter A. Refuge Point, WRC (2020) CC

With 71 million people forcibly displaced around the world and aid budgets woefully underfunded, how do humanitarian agencies decide whom to help and for how long?

Download (393)

View PDF (477)

Strategic Plan of the Pan American Health Organization 2020-2025: Equity at the Heart of Health

Pan American Health Organisation PAHO (2020) C_WHO

Under the theme Equity at the Heart of Health, this Plan seeks to catalyze efforts in Member States to reduce inequities in health within and between countries and territories in order to improve health outcomes. The Plan identifies specific actions to tackle health inequality, including those recom... more

Download (399)

View PDF (431)

The United Nations Convention on the rights of the child and implications for clinical, practice, policy and research

M. L. Belfer; S. Song IACAPAP (2012) C2

Miscellaneous Chapter J.7

Download (1189)

View PDF (989)

Nepal: Statistics & Information of MDR and XDR TB in SAARC Region

SAARC TB and HIVAIDS Centre (STAC) (2016) C1

Download (526)

View PDF (399)

Inter-Agency Reproductive Health Kits 6th Edition - Manual

Inter-Agency Working Group on Reproductive Health in Crisis IAWG and UNFPA (2021) C1

Download (468)

View PDF (1069)

Sudan: Multi-Year Humanitarian Strategy 2017-2019

UN Office for the Coordination of Humanitarian Affairs (2017) C1

Download (517)

View PDF (441)

Monitoring and surveillance of antimicrobial resistance in bacteria from healthy food animals intended for consumption

Food and Agriculture Organization of the United Nations FAO (2019) C2

The animal health subsector within the agriculture sector is the gatekeeper of antimicrobial resistance (AMR) in livestock, aquaculture, animal products, and the immediate animal environment. In support of member countries taking responsibility for and moving forward with putting AMR monitoring and ... more

Download (511)

View PDF (493)

Saving Mothers, Giving Life. Maternal Mortality Endline Census in Selected Districts

Central Statistical Office (CSO) Zambia, Ministry of Health (MOH) Zambia, and ICF, et al. (2017) C1

Download (495)

View PDF (576)

Planning, Monitoring and Evaluation. Webinar 14. Companion Technical Booklet

Mont, D. UNICEF (2014)

Download (397)

View PDF (500)

Innovation in deinstitutionalization: a WHO expert survey

World Health Organization WHO (2014) C_WHO

Based on the survey, five principles for deinstitutionalization were identified: community-based services must be in place; the health workforce must be committed to change; political support at the highest and broadest levels is crucial; timing is key; and additional financial resources are needed.

Download (589)

View PDF (782)

Therapeutics and COVID-19 (Living Guideline, 10 November 2023)

World Health Organization WHO (2023) C_WHO

WHO has updated its guidelines for COVID-19 therapeutics, with revised recommendations for patients with non-severe COVID-19. This is the 13th update to these guidelines. Updated risk rates for hospital admission in patients with non-severe COVID-19 The guidance includes updated risk rates for... hospital admission in patients with non-severe COVID-19. The current COVID-19 virus variants tend to cause less severe disease while immunity levels are higher due to vaccination, leading to lower risks of severe illness and death for most patients. This update includes new baseline risk estimates for hospital admission in patients with non-severe COVID-19. The new ‘moderate risk’ category now includes people previously considered to be high risk including older people and/or those with chronic conditions, disabilities, and comorbidities of chronic disease. The updated risk estimates will assist healthcare professionals to identify individuals at high, moderate or low risk of hospital admission, and to tailor treatment according to WHO guidelines: **High: **People who are immunosuppressed remain at higher risk if they contract COVID-19, with an estimated hospitalization rate of 6%. **Moderate: **People over 65 years old, those with conditions like obesity, diabetes and/or chronic conditions including chronic obstructive pulmonary disease, kidney or liver disease, cancer, people with disabilities and those with comorbidities of chronic disease are at moderate risk, with an estimated hospitalization rate of 3%. Low: Those who are not in the high or moderate risk categories are at low risk of hospitalization (0.5%). Most people are low risk. Review of COVID-19 treatments for people with non-severe COVID-19 WHO continues to strongly recommend nirmatrelvir-ritonavir (also known by its brand name ‘Paxlovid’) for people at high-risk and moderate risk of hospitalization. The recommendations state that nirmatrelvir-ritonavir is considered the best choice for most eligible patients, given its therapeutic benefits, ease of administration and fewer concerns about potential harms. Nirmatrelvir-ritonavir was first recommended by WHO in April 2022. If nirmatrelvir-ritonavir is not available to patients at high-risk of hospitalization, WHO suggests the use of molnupiravir or remdesivir instead. WHO suggests against the use of molnupiravir and remdesivir for patients at moderate risk, judging the potential harms to outweigh the limited benefits in patients at moderate risk of hospital admission. For people at low risk of hospitalization, WHO does not recommend any antiviral therapy. Symptoms like fever and pain can continue to be managed with analgesics like paracetamol. WHO also recommends against use of a new antiviral (VV116) for patients, except in clinical trials. The update also includes a strong recommendation against the use of ivermectin for patients with non-severe COVID-19. WHO continues to advise that in patients with severe or critical COVID-19, ivermectin should only be used in clinical trials. more